Clarification: Feb 21, 2003

Feb 21, 2003

Premium

On Jan. 24, Mike Garrett, a brand manager at Serologicals, was quoted as saying the company’s Amplifluor PCR technology “substantially decreases the risk of allelic discrimination.” In fact, the Amplifluor technology decreases the risk of allelic bias.

Filed under

Diagnostics

Breaking News

Analysis of Ancient Plaque Points to Agriculture-Related Oral Microbiome Changes in Southern Europe
Gene-Disrupting Ultra-Rare Variants More Common in Children With Autism Spectrum Disorder
CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance
Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business
Top Five Articles on GenomeWeb Last Week: Pacific Biosciences, Illumina, Natera, and More
Canine Genetics Firm Embark Veterinary Raises $75M in Series B Round

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.